amoxicillin clavulanate ES
Selected indexed studies
- Antibiotic treatment of acute and recurrent otitis media in children: an Italian intersociety Consensus. (Ital J Pediatr, 2025) [PMID:39980042]
- Amoxicillin/clavulanate for infections in infants and children: past, present and future. (Pediatr Infect Dis J, 2003) [PMID:14567000]
- Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network. (Clin Gastroenterol Hepatol, 2025) [PMID:38992407]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Amoxicillin/clavulanate for infections in infants and children: past, present and future. (2003) pubmed
- Antibiotic treatment of acute and recurrent otitis media in children: an Italian intersociety Consensus. (2025) pubmed
- Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network. (2025) pubmed
- Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. (2004) pubmed
- A European survey on anaerobes from paediatric blood cultures: a comparative analysis with adults. (2025) pubmed
- Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars. (2014) pubmed
- Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis? (2005) pubmed
- Intravenous amoxicillin/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial. (2016) pubmed
- Antimicrobial activity of piperacillin/tazobactam against key peri-implant pathogens: an in vitro comparative study with amoxicillin-clavulanate and minocycline. (2025) pubmed
- Vonoprazan-based therapy versus standard regimen for Helicobacter pylori infection management in Egypt: an open-label randomized controlled trial. (2025) pubmed